Literature DB >> 3793655

Amantadine resistance in clinical influenza A (H3N2) and (H1N1) virus isolates.

R M Pemberton, R Jennings, C W Potter, J S Oxford.   

Abstract

Thirty-nine influenza A (H1N1) and (H3N2) virus isolates were examined for their susceptibility to amantadine in allantois-on-shell (AOS) cultures. A range of susceptibilities was found when isolates were titrated in the presence of 2.5 mg/l amantadine. Further titration of resistant isolates at 25 mg/l revealed one isolate which remained totally resistant at this higher concentration. A series of cloned viruses was derived from this resistant isolate, and one other partially resistant isolate, by limiting dilution AOS passage in the absence of amantadine. When these were titrated in the presence of 25 mg/l amantadine, a heterogeneity of amantadine-resistance phenotypes was observed in both sets of virus clones. Finally, chronological ordering of clinical isolates and reference strains tested in this study suggests a higher incidence of amantadine resistance amongst more recent influenza A virus isolates.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3793655     DOI: 10.1093/jac/18.supplement_b.135

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Chemoprophylaxis of influenza A virus infections, with single doses of zanamivir, demonstrates that zanamivir is cleared slowly from the respiratory tract.

Authors:  R J Fenton; P J Morley; I J Owens; D Gower; S Parry; L Crossman; T Wong
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

2.  Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection.

Authors:  R B Belshe; M H Smith; C B Hall; R Betts; A J Hay
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

Review 3.  Amantadine and rimantadine for influenza A in children and the elderly.

Authors:  Márcia G Alves Galvão; Marilene Augusta Rocha Crispino Santos; Antonio J L Alves da Cunha
Journal:  Cochrane Database Syst Rev       Date:  2014-11-21

Review 4.  Persistent herpes simplex virus infection and mechanisms of virus drug resistance.

Authors:  H J Field
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-08       Impact factor: 3.267

5.  4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro.

Authors:  J M Woods; R C Bethell; J A Coates; N Healy; S A Hiscox; B A Pearson; D M Ryan; J Ticehurst; J Tilling; S M Walcott
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

6.  Relation between drug resistance and antigenicity among norakin-resistant mutants of influenza A (fowl plague) virus.

Authors:  A I Klimov; S G Markushin; S Prösch; V P Ginzburg; H Heider; A M Heider; C Schröeder; R G Webster
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

7.  Duration of Influenza Virus Shedding Among HIV-Infected Adults in the cART Era, 2010-2011.

Authors:  Pragna Patel; Timothy Bush; E Milu Kojic; Edgar T Overton; Keith Henry; Nur Önen; Frank Rhame; Lois Conley; John T Brooks; Alicia Fry
Journal:  AIDS Res Hum Retroviruses       Date:  2016-06-13       Impact factor: 2.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.